Skip to main navigation
Skip to search
Skip to main content
University of Johannesburg Home
Search content at University of Johannesburg
Home
Scholars
Research entities
Research output
Press/Media
Equipment & facilities
Prestigious awards
MicroRNA-383: A tumor suppressor miRNA in human cancer
Abdollah Jafarzadeh
, Majid Noori
, Shaghayegh Sarrafzadeh
, Seyed Saeed Tamehri Zadeh
, Maryam Nemati
, Nazanin Chatrabnous
, Sara Jafarzadeh
,
Michael R. Hamblin
, Mohammad Hassan Jafari Najaf Abadi
, Hamed Mirzaei
Laser Research Centre
Kerman University of Medical Sciences
Rafsanjan University of Medical Sciences
Aja University of Medical Sciences
Shahid Beheshti University of Medical Sciences
Tehran University of Medical Sciences
Shiraz University of Medical Sciences
Mashhad University of Medical Sciences
Kashan University of Medical Sciences and Health Services
Research output
:
Contribution to journal
›
Review article
›
peer-review
27
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MicroRNA-383: A tumor suppressor miRNA in human cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
microRNA
100%
Tumor Suppressor Protein
100%
Neoplasm
83%
Cancer Stem Cell
16%
Lung Cancer
16%
Chemotherapeutic Agent
16%
Cancer Cell
16%
Prostate Cancer
16%
Head and Neck Cancer
16%
Programmed Cell Death
16%
Cell Proliferation
16%
Ovarian Cancer
16%
Angiogenesis
16%
Cervical Cancer
16%
Anticarcinogen
16%
Breast Cancer
16%
Mouth Squamous Cell Carcinoma
16%
B-Cell Lymphoma
16%
Nodular Melanoma
16%
Tumor Gene
16%
Esophageal Cancer
16%
Thyroid Cancer
16%
Medulloblastoma
16%
Pancreas Cancer
16%
Cholangiocarcinoma
16%
Hepatocellular Carcinoma
16%
Colorectal Cancer
16%
Mesenchymal-Epithelial Transition
16%
Immunosuppressive Treatment
16%
Ganglioglioma
16%
Drug Resistance
16%
Untranslated Region
16%
Stomach Cancer
16%
Keyphrases
MicroRNA-383
100%
Tumor Suppressor miRNA
100%
Human Cancer
100%
MiR-383
100%
Pro-tumor
42%
Potential Treatments
28%
Gene Treatment
14%
Tumor Effect
14%
Thyroid Cancer Cells
14%
Immunosuppression
14%
Hepatocellular Carcinoma
14%
Tumor Inhibitor
14%
Tumor-related Genes
14%
Glioma
14%
Medulloblastoma
14%
B-cell Lymphoma
14%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
14%
Carcinoma Thyroid
14%
Downstream Target Genes
14%
Antitumor
14%
Esophageal Cancer
14%
Glycolysis
14%
Cholangiocarcinoma
14%
Cancer Lung
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Suppressor Protein
100%
Malignant Neoplasm
100%
microRNA
100%
Neoplasm
85%
Colorectal Cancer
14%
Liver Cell Carcinoma
14%
Esophagus Cancer
14%
Lung Cancer
14%
Anticarcinogen
14%
Uterine Cervix Cancer
14%
Breast Cancer
14%
Drug Resistance
14%
Melanoma
14%
Pancreas Cancer
14%
Prostate Cancer
14%
Ovary Cancer
14%
Stomach Cancer
14%
Bile Duct Carcinoma
14%
Mouth Squamous Cell Carcinoma
14%
B Cell Lymphoma
14%
Head and Neck Cancer
14%
Medulloblastoma
14%
Thyroid Cancer
14%